AMWL:NYE-American Well Corp (USD)

COMMON STOCK | Health Information Services | NYE

Last Closing Price

USD 5.11

Change

+0.23 (+4.71)%

Market Cap

USD 1.39B

Volume

1.46M

Avg Analyst Target

USD 5.60 (+9.59%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


AMWL Stock Forecast & Price:
Based on the American Well Corp stock forecasts from 4 analysts, the average analyst target price for American Well Corp is USD 5.60 over the next 12 months. American Well Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of American Well Corp is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, American Well Corp’s stock price was USD 5.11. American Well Corp’s stock price has changed by +11.82% over the past week, +8.03% over the past month and -52.15% over the last year.

About American Well Corp (AMWL:NYE)

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. It ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-10 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VEEV Veeva Systems Inc Class A

+6.04 (+2.72%)

USD34.38B 87.42 60.86
DOCS Doximity Inc

+3.45 (+9.45%)

USD7.77B 58.01 55.08
TDOC Teladoc Inc

+2.38 (+6.72%)

USD5.72B N/A -0.72
EVH Evolent Health Inc

+0.53 (+1.51%)

USD3.21B N/A 59.27
AGTI Agiliti Inc

-1.31 (-7.14%)

USD2.44B 79.78 13.22
PHR Phreesia Inc

+2.28 (+9.61%)

USD1.39B 2.91 -8.30
CNVY Convey Holding Parent Inc

-0.01 (-0.10%)

USD0.76B N/A 28.41
BBLN Babylon Holdings Ltd

-0.06 (-6.88%)

USD0.38B N/A -1.12
CSLT Castlight Health Inc

N/A

USD0.34B N/A N/A
2175 SMS Co Ltd

N/A

N/A N/A N/A

ETFs Containing AMWL

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -15.40% 67% D+ 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.40% 67% D+ 32% F
Trailing 12 Months  
Capital Gain -50.29% 38% F 8% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -50.29% 38% F 7% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -13.42% 13% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.42% 13% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 326.98% 13% F 2% F
Risk Adjusted Return -4.10% 25% F 21% F
Market Capitalization 1.39B 44% F 56% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 1.14 89% B+ 65% D
Price / Cash Flow Ratio -9.85 78% C+ 88% B+
EV/EBITDA -3.18 89% B+ 86% B
Management Effectiveness  
Return on Equity -20.29% 44% F 11% F
Return on Invested Capital -14.11% 33% F 9% F
Return on Assets -12.08% 33% F 5% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 4.22 56% F 24% F
Short Percent 4.28% 67% D+ 48% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.